Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy

Zhou, Mengyao; Ta, Shengjun; T. Hahn, Rebecca; H. Hsi, David; B. Leon, Martin; Hu, Rui; Zhang, Jun; Zuo, Lei; Li, Jing; Wang, Jing; Wang, Bo; Zhu, Xiaoli; Liu, Jiani; Han, Yupeng; Li, Xiaojuan; Xu, Bo; Zhang, Lei; Hou, Lihong; Han, Chao; Liu, Jincheng; Liu, Liwen

doi:10.1001/jamacardio.2022.0259

Public

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy

Published in JAMA Cardiology • Mar 30, 2022

Authors:

Mengyao Zhou

Shengjun Ta

Rebecca T. Hahn

Abstract

Importance: Patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms and outflow gradients have limited nonsurgical treatment options. The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) has been reported previously; however, proce...

Subject

Medicine

Alcohol septal ablation

Cardiology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!